What is it all about?

The Global Health Catalyst has been funded by the  Brigham and Women’s Hospital, and Dana-Farber Cancer Institute, Harvard Medical School, and seed funding from the Radcliffe Institute for Advanced Studies at Harvard University, and recently a growing number of  funding agencies and industry partners with goal to catalyze high impact international collaborations  and initiatives to eliminate global health disparities, with main focus on cancer and other non-communicable diseases.

We have a dream that one day cancer will be eradicated,  and that people of all socio-economic, racial, religious, and cultural backgrounds will have access to quality healthcare.

To realize this dream, we have adopted a transformative approach rooted in the values of creative agency and collaborative work embodied in the word UBUNTU. Popularized worldwide by Nobel Prize winners Desmond Tutu and Nelson Mandela, ubuntu signifies the idea that “I am because we are,” or human connectedness. This ethos rings particularly true in today’s hyperconnected world, where we all share in the bounty of the expanding internet or ICTs and where local health has become global health and vice versa. Based on this values, our approach, focuses on building collaborations, leveraging ICTs/lower cost technologies, and unprecedented diaspora engagement to catalyze high impact international collaborations to eliminate global health disparities, save lives, advance development.


  • Research: Developing low-cost technologies and approaches for global health, global radiation oncology
  • Care: ICT-powered telemedicine, remote treatment planning and quality assurance via our win-win initiative to dramatically increase access to quality cancer care at ecancer4all
  • Outreach: building partnerships with industry, Non-profit Organizations, celebrities, government leaders, and the resource-laden diaspora


    • 2015 BRIght Futures Prize on the development of “Tiny Drones to Target Cancer” designed to eliminate both local and metastatic disease responsible for over 90% of cancer deaths. The technology is also expected to significantly reduce treatment times and cost allowing for over 16 patients to be treated in the time it takes to treat one currently.
    • Awards including over 120 travel/professional development awards to Harvard Medical School to learn, network and start new  international collaborations to eliminate cancer,
    • Fellowships  for trainees in Africa
    • Peer-reviewed Publications,
    • Three Books by IOP publishing including yearly summit proceedings
    • Catalyzing establishment/support for a growing number of cancer  centers and academic institutions, including in Kenya, Cameroon, Rwanda, Tanzania, Nigeria and South Africa
    • Global Oncology University
    • Co-mentored research involving faculty mentors from the Dana-Farber/Harvard Cancer Center and LMIC Institutions in Africa
    • Telemedicine and tumor boards with diaspora participation
    • Unprecedented partnerships with sports, religion, industry, diaspora, to address global health disparities,
  •  Knowledge sharing and continuous education at our yearly Global Health Catalyst summits
  • 2018 Launch of the first major phytomedicines initiative in global health